Quarterly report pursuant to Section 13 or 15(d)

LOSS PER SHARE

v3.19.1
LOSS PER SHARE
3 Months Ended
Mar. 31, 2019
LOSS PER SHARE [Text Block]

NOTE 7 – LOSS PER SHARE

            The following table sets forth the calculation of basic and diluted loss per share for the period indicated:

                Transition  
                Period One  
    Three M ont hs Ended     Month Ended  
    March 31,     February 28,     December 31,  
    2019     2018     2018  
    (in th ousands, except per share data)  
Basic:                  
                   
Net loss attributable to Orgenesis Inc. $ 8,311   $ 5,611   $ 2,744  
Adjustment of redeemable non-controlling interest to redemption amount   242     -     180  
Net loss attributable to Orgenesis Inc. for loss per share   8,553     5,611     2,924  
Weighted average number of common shares outstanding   15,571,568     10,775,877     15,423,040  
                   
                   
Loss per common share $ 0.55   $ 0.52   $ 0.19  
Diluted :                  
Net loss attributable to Orgenesis Inc. for loss per share   8,553     5,611     2,924  
Weighted average number of shares used in the computation of basic and diluted loss per share   15,571,568     10,775,877     15,423,040  
                   
Loss per common share $ 0.55   $ 0.52   $ 0.19  

            For the one month ended December 31, 2018 and the three months ended March 31, 2019, all outstanding convertible notes, options and warrants have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive. Diluted loss per share does not include 4,981,019 shares underlying outstanding options and warrants and 1,176,286 shares upon conversion of convertible loans for the three months ended February 28, 2018, because the effect of their inclusion in the computation would be anti-dilutive.